Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals

Journal of Neuroscience

Volumn 26, Issue 10, 2006, Pages 2661-2672

  Pagani, Mario R ^a   Reisin, Ricardo C ^b   Uchitel, Osvaldo D ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

Author keywords

Calcium channels; Calcium homeostasis alteration; IP3R; Phospholipase C; RyR; Signaling mechanisms

Indexed keywords

CALCIUM; CALCIUM CHANNEL N TYPE; CALCIUM ION; IMMUNOGLOBULIN G; INOSITOL TRISPHOSPHATE; NEUROTRANSMITTER; PHOSPHOLIPASE C; PROTEINASE; RYANODINE RECEPTOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTOIMMUNITY; CALCIUM SIGNALING; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE; MOTONEURON; MOUSE; NERVE ENDING; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, N-TYPE; CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; ELECTRIC STIMULATION; ENZYME INHIBITORS; EVOKED POTENTIALS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MICE; MIDDLE AGED; MUSCLE FIBERS; NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER AGENTS; OMEGA-CONOTOXIN GVIA; PHOSPHOLIPASE C; PRESYNAPTIC TERMINALS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; STATISTICS; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 33644829010     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4394-05.2006     Document Type: Article

References (65)

1. Andjus PR, Stevic-Marinkovic Z, Cherubini E (1997) Immunoglobulins from motoneurone disease patients enhance glutamate release from rat hippocampal neurones in culture. J Physiol (Lond) 504:103-112.
2. 2+ and spontaneous transmitter release at the frog neuromuscular junction. J Neurophysiol 85:287-294.
3. Arsac C, Raymond C, Martin-Moutot N, Dargent B, Couraud F, Pouget J, Seagar M (1996) Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum. Ann Neurol 40:695-700.
4. Athanassakis I, Protopapadakis E, Vassiliadis S (2000) Localization of pepstatin's inhibitory action during Fc-mediated antibody internalization: possible implications for antibody-mediated viral transmission. Cell Immunol 199:81-88.
5. Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517-529.
6. Brooks BR, Shodis KA, Lewis DH, Rawling JD, Sanjak M, Belden DS, Hakim H, DeTan Y, Gaffney JM (1995) Natural history of amyotrophic lateral sclerosis. Quantification of symptoms, signs, strength, and function. Adv Neurol 68:163-184.
7. Bullens RW, O'Hanlon GM, Wagner E, Molenaar PC, Furukawa K, Plomp JJ, Willison HJ (2002) Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci 22:6876-6884.
8. Chio A, Benzi G, Dossena M, Mutani R, Mora G (2005) Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128:472-476.
9. Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2:806-819.
10. Cui LY, Liu MS, Tang XF (2004) Single fiber electromyography in 78 patients with amyotrophic lateral sclerosis. Chin Med J (Engl) 117:1830-1833.
11. 2+ uptake prevents desynchronization of quantal release and minimizes depletion during repetitive stimulation of mouse motor nerve terminals. J Physiol (Lond) 548:425-438.
12. Day NC, Wood SJ, Ince PG, Volsen SG, Smith W, Slater CR, Shaw PJ (1997) Differential localization of voltage-dependent calcium channel α1 subunits at the human and rat neuromuscular junction. J Neurosci 17:6226-6235.
13. Delbono O, Garcia J, Appel SH, Stefani E (1991) Calcium current and charge movement of mammalian muscle: action of amyotrophic lateral sclerosis immunoglobulins. J Physiol (Lond) 444:723-742.
14. Demestre M, Pullen A, Orrell RW, Orth M (2005) ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures. J Neurochem 94:268-275.
15. Doughty SW, Blaney FE, Orlek BS, Richards WG (1998) A molecular mechanism for toxin block in N-type calcium channels. Protein Eng 11:95-99.
16. Drachman DB (2000) Does autoimmunity play a role in amyotrophic lateral sclerosis? In: Amyotrophic lateral sclerosis (Brown RH, Meininger V, Swash M, eds), pp 327-339. London: Dunitz.
17. Engelhardt JI, Siklos L, Komuves L, Smith RG, Appel SH (1995) Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 20:185-199.
18. Engelhardt JI, Siklos L, Appel SH (1997) Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J Neuropathol Exp Neurol 56:21-39.
19. Fratantoni SA, Weisz G, Pardal AM, Reisin RC, Uchitel OD (2000) Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker. Muscle Nerve 23:543-550.
20. Guegan C, Vila M, Rosoklija G, Hays AP, Przedborski S (2001) Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J Neurosci 21:6569-6576.
21. Hua SY, Raciborska DA, Trimble WS, Charlton MP (1998) Different VAMP/synaptobrevin complexes for spontaneous and evoked transmitter release at the crayfish neuromuscular junction. J Neurophysiol 80:3233-3246.
22. Jayaraman T, Marks AR (1997) T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol Cell Biol 17:3005-3012.
23. 2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction. Br J Pharmacol 121:1531-1540.
24. 2+ channel alpha 1 subunit. Ann Neurol 35:164-171.
25. Llinas R, Sugimori M, Cherksey BD, Smith RG, Delbono O, Stefani E, Appel S (1993) IgG from amyotrophic lateral sclerosis patients increases current through P-type calcium channels in mammalian cerebellar Purkinje cells and in isolated channel protein in lipid bilayer. Proc Natl Acad Sci USA 90:11743-11747.
26. Maselli RA, Wollman RL, Leung C, Distad B, Palombi S, Richman DP, Salazar-Grueso EF, Roos RP (1993) Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve 16:1193-1203.
27. McEnery MW, Snowman AM, Snyder SH (1994) The association of endogenous Go alpha with the purified omega-conotoxin GVIA receptor. J Biol Chem 269:5-8.
28. Medesan C, Cianga P, Mummert M, Stanescu D, Ghetie V, Ward ES (1998) Comparative studies of rat IgG to further delineate the Fc:FcRn interaction site. Eur J Immunol 28:2092-2100.
29. 2+ channels. Neuron 17:781-788.
30. Mohamed HA, Mosier DR, Zou LL, Siklos L, Alexianu ME, Engelhardt JI, Beers DR, Le WD, Appel SH (2002) Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin-mediated calcium increase, and neurotransmitter release in motor neurons. J Neurosci Res 69:110-116.
31. 2+ currents in a motoneuron cell line. Ann Neurol 37:102-109.
32. Mosier DR, Siklos L, Appel SH (2000) Resistance of extraocular motoneuron terminals to effects of amyotrophic lateral sclerosis sera. Neurology 54:252-255.
33. Muchnik S, Losavio A, Lorenzo SD (2002) Effect of amyotrophic lateral sclerosis serum on calcium channels related to spontaneous acetylcholine release. Clin Neurophysiol. 113:1066-1071.
34. 2+ channels to ryanodine receptors at presynaptic terminals. Amplification of exocytosis and plasticity. J Gen Physiol 115:519-532.
35. Norris Jr FH, Gasteiger EL (1955) Action potentials of single motor units in normal muscle. Electroencephalogr Clin Neurophysiol Suppl 7:115-125.
36. Nyormoi O (1996) Proteolytic activity in amyotrophic lateral sclerosis IgG preparations. Ann Neurol 40:701-706.
37. Ober RJ, Radu CG, Ghetie V, Ward ES (2001) Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol 13:1551-1559.
38. Offen D, Halevi S, Orion D, Mosberg R, Stern-Goldberg H, Melamed E, Atlas D (1998) Antibodies from ALS patients inhibit dopamine release mediated by L-type calcium channels. Neurology 51:1100-1103.
39. Ordonez G, Sotelo J (1989) Antibodies against fetal muscle proteins in serum from patients with amyotrophic lateral sclerosis. Neurology 39:683-686.
40. Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 4:552-565.
41. O'Shaughnessy TJ, Yan H, Kim J, Middlekauff EH, Lee KW, Phillips LH, Kim YI (1998) Amyotrophic lateral sclerosis: serum factors enhance spontaneous and evoked transmitter release at the neuromuscular junction. Muscle Nerve 21:81-90.
42. Otsu Y, Murphy TH (2004) Optical postsynaptic measurement of vesicle release rates for hippocampal synapses undergoing asynchronous release during train stimulation. J Neurosci 24:9076-9086.
43. 2+ channel knockout mouse. Neuroscience 123:75-85.
44. Protti DA, Szczupak L, Scornik FS, Uchitel OD (1991) Effect of omega-conotoxin GVIA on neurotransmitter release at the mouse neuromuscular junction. Brain Res 557:336-339.
45. Pullen AH, Humphreys P (2000) Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls. J Neurol Sci 180:35-45.
46. 2+ enhancement. Acta Neuropathol (Berl) 107:35-46.
47. Rizzoli SO, Betz WJ (2002) Effects of 2-(4-morpholinyl)-8-phenyl-4H-1- benzopyran-4-one on synaptic vesicle cycling at the frog neuromuscular junction. J Neurosci 22:10680-10689.
48. 2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science 262:744-747.
49. Robidoux J, Simoneau L, St-Pierre S, Ech-Chadli H, Lafond J (1998) Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis. Am J Physiol 274:E502-E509.
50. Sara Y, Virmani T, Deak F, Liu X, Kavalali ET (2005) An isolated pool of vesicles recycles at rest and drives spontaneous neurotransmission. Neuron 45:563-573.
51. Schiavo G, Gu QM, Prestwich GD, Sollner TH, Rothman JE (1996) Calcium-dependent switching of the specificity of phosphoinositide binding to synaptotagmin. Proc Natl Acad Sci USA 93:13327-13332.
52. Siklos L, Engelhardt J, Harati Y, Smith RG, Joo F, Appel SH (1996) Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann Neurol 39:203-216.
53. Smith RG, Hamilton S, Hofmann F, Schneider T, Nastainczyk W, Birnbaumer L, Stefani E, Appel SH (1992) Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 327:1721-1728.
54. Smith RG, Alexianu ME, Crawford G, Nyormoi O, Stefani E, Appel SH (1994) Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci USA 91:3393-3397.
55. Smith SA, Miller RG, Murphy JR, Ringel SP (1994) Treatment of ALS with high dose pulse cyclophosphamide. J Neurol Sci [Suppl] 124:84-87.
56. Stoop R, Poo MM (1995) Potentiation of transmitter release by ciliary neurotrophic factor requires somatic signaling. Science 267:695-699.
57. Strong MJ (2003) The basic aspects of therapeutics in amyotrophic lateral sclerosis. Pharmacol Ther 98:379-414.
58. Thomas MM, Dunn SM (1997) Amyotrophic lateral sclerosis immunoglobulins are ineffective in altering calcium influx through presynaptic voltage-sensitive calcium channels. Neurol Res 19:129-134.
59. Troost D, Van den Oord JJ, Vianney de Jong JM (1990) Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 16:401-410.
60. Uchitel OD, Appel SH, Crawford F, Sczcupak L (1988) Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals. Proc Natl Acad Sci USA 85:7371-7374.
61. Uchitel OD, Scornik F, Protti DA, Fumberg CG, Alvarez V, Appel SH (1992) Long-term neuromuscular dysfunction produced by passive transfer of amyotrophic lateral sclerosis immunoglobulins. Neurology 42:2175-2180.
62. Vincent A (1999) Immunology of the neuromuscular junction and presynaptic nerve terminal. Curr Opin Neurol 12:545-551.
63. 2+ currents in mice dorsal root ganglion neurons. Neurosci Lett 235:69-72.
64. Yang F, He X, Feng L, Mizuno K, Liu XW, Russell J, Xiong WC, Lu B (2001) PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation. Nat Neurosci 4:19-28.
65. 2+ currents of rat cerebellar granule cells in culture. Neurosci Lett 172:111-114.